Sands Capital Ventures »

Inhibikase Therapeutics shares owned by Sands Capital Ventures

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Sands Capital Ventures from 13F filings

Historical chart of Sands Capital Ventures investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Sands Capital Ventures

Quarter filed Position value Share count Share price at filing
2025-09-30 $18M 11M 1.62
2025-06-30 $21M 11M 1.95
2025-03-31 $24M 11M 2.19
2024-12-31 $36M 11M 3.25